Recruiting Interstitial Lung Disease Studies in Chapel Hill
About Interstitial Lung Disease Clinical Trials in Chapel Hill
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 6 interstitial lung disease clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 4,194 participants. Research is being sponsored by University of North Carolina, Chapel Hill, Johns Hopkins University, University of Michigan and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in Chapel Hill — FAQ
Are there interstitial lung disease clinical trials in Chapel Hill?
Yes, there are 6 interstitial lung disease clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chapel Hill?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.
Are clinical trials in Chapel Hill free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 6 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated July 13, 2026 from ClinicalTrials.gov